Accessibility Menu
Underwood Capital logo

Underwood Capital(OTC) MMJJF

Market Cap$8.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-85%
5 Year-29%
1 Year+28%
1 Month-1%
$0.04
+0.00%
+0.00Today
Underwood Capital last closing stock price
MetricPriceDate
Last closeUSD 0.042026-08-28
Underwood Capital stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+22.7%USD 0.032026-08-13
1 month-0.83%USD 0.042026-07-22
3 month+11.42%USD 0.042026-05-22
Year to date-5.44%USD 0.042025-12-26
1 year+27.8%USD 0.032025-08-20
3 year+25.79%USD 0.032023-08-29
5 year-29.33%USD 0.062021-08-26
Since inception-84.62%USD 0.262017-05-30

Underwood Capital Financials at a Glance

Market Cap

$8.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

-A$4.34M

Net Income (TTM)

A$439.12K

EPS (TTM)

-$0.00

P/E Ratio

-200.00

Dividend

$0.00

Beta (Volatility)

-0.32 (Low)

Price

$0.04

Volume

10,000

Open

$0.04

Previous Close

$0.04

Daily Range

$0.04 - $0.04

52-Week Range

$0.03 - $0.05

Estimated Earnings Date

Feb 18, 2026

MMJJF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Underwood Capital

Underwood Capital Limited is an investment holding entity focused on the commercialization of cannabis for medical applications. Established in 2014 and headquartered in Sydney, Australia, the company operates within the asset management industry.

Products and Services
  • Investment holding in cannabis-related ventures
  • Focus on medical cannabis commercialization
  • Asset management services for investors
Growth Outlook
  • Recent quarterly net income of AUD 3.36 million indicates strong profitability
  • Trailing twelve months (TTM) P/E ratio of 3.74 suggests potential undervaluation
  • Cash and short-term investments of AUD 26.6 million provide financial stability
Financial Highlights
  • Quarterly revenue of AUD 1.2 million in Q4 2024 shows positive growth
  • Net income increased significantly from AUD -779,000 to AUD 3.36 million
  • Current ratio of 19.17 indicates strong liquidity position
Underwood Capital Limited presents a compelling opportunity for investors interested in the burgeoning medical cannabis sector. The company's recent financial performance demonstrates a significant turnaround, with a notable increase in net income and a solid current ratio, reflecting its ability to meet short-term obligations. The low P/E ratio may suggest that the stock is undervalued, providing potential for future appreciation. With a robust cash position, Underwood Capital is well-positioned to capitalize on growth opportunities in the medical cannabis market.
AI Generated • Aug 15, 2026

Industry

Capital Markets

CEO

Jason Conroy, MBA, CPA

Headquarters

Sydney, NSW 2000, AU

MMJJF Financials

Key Financial Metrics (TTM)

Gross Margin

100.00%

Operating Margin

-842.40%

Net Income Margin

26.92%

Return on Equity

0.92%

Return on Capital

-0.81%

Return on Assets

0.91%

Earnings Yield

-0.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

202.56M

Volume

10.00K

Avg. Volume

414.656

Financials (TTM)

Gross Profit

A$1.57M

Operating Income

-A$7.57M

EBITDA

A$395.65K

Operating Cash Flow

A$810.00K

Capital Expenditure

A$0.00

Free Cash Flow

A$810.00K

Cash & ST Invst.

A$21.14M

Total Debt

A$0.00

Underwood Capital Performance Analysis

Underwood Capital annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 115,705N/A
20242024-06-30AUD 286,399147.5%
20252025-06-30AUD -384,045N/A
20262026-06-30AUD 937,153N/A
Underwood Capital sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-310.4%
Q42025-06-30-129.1%
Q22025-12-31100.0%
Q42026-06-30N/A
Underwood Capital annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.01-76.7%
20242024-06-30AUD -0.00-96.6%
20252025-06-30AUD 0.00N/A
20262026-06-30AUD 0.00-25.0%
Underwood Capital sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-6.5%
Q42025-06-30-158.6%
Q22025-12-311058.8%
Q42026-06-30-195.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

-A$5.20M

-533.2%

Gross Profit

A$720.37K

-40.0%

Gross Margin

-13.86%

N/A

Market Cap

$8.10MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

-A$3.17M

-588.5%

EBITDA

A$1.05M

+24.0%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$21.14M

-2.7%

Total Debt

A$0.00

N/A

Accounts Receivable

A$0.00

-100.0%

Inventory

A$0.00

N/A

Long Term Debt

A$0.00

N/A

Short Term Debt

A$0.00

N/A

Return on Assets

0.91%

N/A

Return on Invested Capital

-28.41%

N/A

Free Cash Flow

A$474.00K

+441.0%

Operating Cash Flow

A$474.00K

+441.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UDOCFUnidoc Health Corp.
$0.10+0.00%
SPLTFSpotLite360 IOT Solutions, Inc.
$0.08+0.00%
TRUFFRhelion Life Sciences Corp.
$0.02+0.00%
FPCGAvem Health Partners, Inc.
$1,025.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.15-0.12%
NVDANvidia
$230.36+0.01%
PATHUiPath
$15.19-0.17%
INTCIntel
$95.80+0.05%

Questions About MMJJF

What is the current price of Underwood Capital?

Underwood Capital is trading at $0.04 per share.

What is the 52-week range for Underwood Capital?

Over the past 52 weeks, Underwood Capital has traded between $0.03 and $0.05.

How much debt does Underwood Capital have?

As of the most recent reporting period, Underwood Capital reported total debt of A$0.00.

How much cash does Underwood Capital have on hand?

Underwood Capital reported A$482.88K in cash and cash equivalents in its most recent financial results.

What is Underwood Capital’s dividend yield?

Underwood Capital does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.